ideasbyjin commited on
Commit
0b4965f
1 Parent(s): 90af908

Prettify license table

Browse files
Files changed (1) hide show
  1. LICENSE.md +3 -3
LICENSE.md CHANGED
@@ -5,9 +5,9 @@ AntiBERTa2 models are antibody-specific Large Language Models (LLM) developed by
5
 
6
  Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights, available for use, reproduction and distribution under this modified version of the Apache 2.0 Licence.
7
 
8
- | | LICENSE SUMMARY | |
9
- | --- | ------ | --- |
10
  | Permissions | Limitations | Conditions |
 
11
  | Private use | No commercial use | Attaching this license |
12
  | Research and academic use | No use for pre-clinical or clinical tests or studies | Notices |
13
  | Creating antibody variants | No developing, generating, or synthesising reagent, diagnostic or therapeutic antibodies for **in vitro** or **in vivo** studies | Attribution |
@@ -16,7 +16,7 @@ Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights,
16
  | Distribution | |
17
 
18
 
19
- TERMS AND CONDITIONS FOR USE, REPRODUCTIONAND DISTRIBUTION OF FABCON
20
  1. Definitions.
21
  "License" shall mean these terms and conditions for use, reproduction, and distribution of the Work as defined by Sections 1 through 9 of this document.
22
  "Licensor" shall mean Alchemab Therapeutics Ltd, the copyright owner or entity authorized by the copyright owner that is granting the License.
 
5
 
6
  Alchemab Therapeutics is making AntiBERTa2, specifically its parameter weights, available for use, reproduction and distribution under this modified version of the Apache 2.0 Licence.
7
 
8
+ ## LICENSE SUMMARY
 
9
  | Permissions | Limitations | Conditions |
10
+ | ----------- | ---------- | ---------- |
11
  | Private use | No commercial use | Attaching this license |
12
  | Research and academic use | No use for pre-clinical or clinical tests or studies | Notices |
13
  | Creating antibody variants | No developing, generating, or synthesising reagent, diagnostic or therapeutic antibodies for **in vitro** or **in vivo** studies | Attribution |
 
16
  | Distribution | |
17
 
18
 
19
+ ## TERMS AND CONDITIONS FOR USE, REPRODUCTIONAND DISTRIBUTION OF FABCON
20
  1. Definitions.
21
  "License" shall mean these terms and conditions for use, reproduction, and distribution of the Work as defined by Sections 1 through 9 of this document.
22
  "Licensor" shall mean Alchemab Therapeutics Ltd, the copyright owner or entity authorized by the copyright owner that is granting the License.